← Back to guidelines
Cardiology83 papers

Small fiber neuropathy

Last edited: 4/15/2026

Overview

Small fiber neuropathy (SFN) involves dysfunction or degeneration of Aδ and C nerve fibers, leading to impaired temperature sensation and neuropathic pain, particularly spontaneous pain 1.

Diagnosis

  • Key Diagnostic Criteria: Impaired temperature perception and spontaneous neuropathic pain 1.
  • Recommended Tests:
  • - Microneurography (MNG) to assess C-nociceptor properties (mechanosensitive vs. mechano-insensitive, normal, hyperactive, or hypoactive) 1. - Quantitative sensory testing (QST) for sensory abnormalities 1. - Intraepidermal nerve fiber density (IENFD) assessment 1.
  • Grading: No specific grading system mentioned in the abstracts, but clinical correlation with sensory deficits and pain ratings is crucial 1.
  • Management

  • First-Line Treatments:
  • - Anticonvulsants (e.g., gabapentin, pregabalin) for neuropathic pain 1. - Antidepressants (e.g., duloxetine, amitriptyline) for pain management 1.
  • Adjunctive Treatments:
  • - Electrical sinusoidal stimulation (eSS) to modulate pain perception 1. - Addressing underlying causes if identifiable (e.g., metabolic disorders, autoimmune conditions) 1.

    Special Populations

  • Chronic Pain and Brain Connectivity: Reduced resting-state functional connectivity, particularly between the caudate nucleus and supplementary motor area, correlates with higher pain levels in idiopathic SFN patients 2.
  • Genetic Influences: Subgroup analyses in patients with Nav channel variants show distinct connectivity patterns, suggesting potential genetic influences on brain reorganization 2.
  • Key Recommendations

  • Utilize microneurography to identify hyperactive C-nociceptors in patients with spontaneous neuropathic pain for targeted management strategies (Evidence: Moderate) 1.
  • Incorporate resting-state fMRI to assess functional connectivity changes in chronic pain patients with SFN, particularly focusing on caudate nucleus connectivity, to guide treatment approaches (Evidence: Moderate) 2.
  • Consider genetic testing in patients with idiopathic SFN to identify potential Nav channel variants, which may influence treatment response and brain connectivity patterns (Evidence: Weak) 2.
  • References

    1 Beisswanger A, Peschke GZ, Braak NWMVD, Dumke C, Fiebig A, Espenkott V et al.. Microneurographic portrait of 19 patients with small fiber neuropathy: a pilot study. Pain 2025. link 2 Scheliga S, Jo HG, Dohrn MF, Kellermann T, Lampert A, Rolke R et al.. Reduced functional resting-state connectivity in chronic pain patients with small fiber neuropathy. The journal of pain 2025. link

    Original source

    1. [1]
      Microneurographic portrait of 19 patients with small fiber neuropathy: a pilot study.Beisswanger A, Peschke GZ, Braak NWMVD, Dumke C, Fiebig A, Espenkott V et al. Pain (2025)
    2. [2]
      Reduced functional resting-state connectivity in chronic pain patients with small fiber neuropathy.Scheliga S, Jo HG, Dohrn MF, Kellermann T, Lampert A, Rolke R et al. The journal of pain (2025)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG